No Evidence for Predictors of Response to Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder

Myriam Harfterkamp*, Dennis van der Meer, Gigi van der Loo-Neus, Jan K. Buitelaar, Ruud B. Minderaa, Pieter J. Hoekstra

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

8 Citations (Scopus)
109 Downloads (Pure)
Original languageEnglish
Pages (from-to)372-375
Number of pages4
JournalJournal of Child and Adolescent Psychopharmacology
Volume25
Issue number4
DOIs
Publication statusPublished - 1-May-2015

Keywords

  • PERVASIVE DEVELOPMENTAL DISORDERS
  • OPEN-LABEL
  • EFFICACY
  • ADHD
  • HYPERACTIVITY
  • PLACEBO
  • SAFETY

Cite this